Pediatrics (HBV Therapy)
"The Efficacy and Side Effects of Interferon alpha 2a (Roferon) on Chronic Hepatitis B Virus Infection in Turkish Children."
Published in Hepatitis Weekly, August 9th, 1999
According to the authors' abstract of an article published in Hepatology Research, "Chronic hepatitis B virus infection in children is a progressive disease. The efficacy of recombinant interferon alpha in the treatment of chronic viral hepatitis B in children is still inconclusive. We evaluated the efficacy of interferon alpha 2a on 32 children aged 1-14 years with chronic hepatitis B. The children received recombinant interferon alpha 2a 5 megaunits/m2 three times weekly for 6 months. Complete response was seen in 31.2% of patients. Twenty-two children aged 3-14 years with chronic hepatitis B showing the similar characteristics were observed without treatment. ...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1999-08-09)
More Articles from Hepatitis Weekly
- Virology (S.E.N. Virus)
Novel Hepatitis Virus Discovered - Coinfection (HCV/HIV)
Hepatitis C Does Not Affect Survival in HIV+ - Disease Progression
Allele May Play Role in HCV-Related Liver Disease - Neurology
IFN-(alpha) Can Induce Mild Encephalopathy - Prognosis
ISDR Doesn't Affect IFN Response in HCV-1b Patients - Proteomics
Histone Binding Site of HCV Identified - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
